Evidence map›Paper›PMID 36308135›Full record

Trial reportIndian journal of ophthalmology2022

Comparison of corneal endothelial cell loss during manual small-incision cataract surgery using viscoelastic-assisted nucleus removal versus continuous balanced salt solution plus technique - Randomized controlled trial.

Arvind Kumar Morya, Bharat Gurnani, Deepak Mishra, Kirandeep Kaur, Amit Porwal, Priya Sisodia, Antarvedi Tejaswini, Logesh Balakrishnan

Erratum issuedOpen access · diamondAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Indian journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Arvind Kumar MoryaDepartment of Ophthalmology, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, India.
Bharat GurnaniCataract, Cornea, Trauma, Ocular Surface, External Diseases, Uvea and Refractive Services, Amritsar, Punjab, India.
Deepak MishraRegional Institute of Ophthalmology, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Kirandeep KaurCataract, Pediatric Ophthalmology and Strabismus Services, Om Parkash Eye Institute, Amritsar, Punjab, India.
Amit PorwalGlaucoma Services, Choitram Netralaya, Indore, Madhya Pradesh, India.
Priya SisodiaCornea and Refractive Services, Sri Satguru Seva Sung Trust, Janki Kund, Chitrakoot, Madhya Pradesh, India.
Antarvedi TejaswiniDepartment of Ophthalmology, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, India.
Logesh BalakrishnanBiostatician, Aravind Eye Hospital, Madurai, Tamil Nadu, India.
All India Institute of Medical Sciences · INAravind Eye Hospital · INBanaras Hindu University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The purpose of this study was to compare and analyze the endothelial cell loss during manual small-incision cataract surgery (MSICS) using the viscoelastic-assisted nucleus removal versus basal salt solution plus technique. Methods: This was a prospective randomized trial of 204 patients who underwent MSICS using viscoelastic-assisted nucleus removal (Group 1- OVD) versus basal salt solution plus technique (Group 2- BSS) at a tertiary eye care hospital in North India from January 2018 to 2021. Of these 204 patients, 103 (50.5%) and 101 (49.5%) were allocated to Group 1 and 2, respectively. The parameters assessed were detailed history, demographics, and anterior and posterior segment details. Visual acuity, intraocular pressure (IOP), keratometry, pachymetry, and endothelial cell density were evaluated preoperatively and postoperatively on day 1 and 30. Results: The mean age of the patients was 64.5 ± 8.2 years (range 48-82 years). There were 129 (63.2%) males and 75 (36.8%) females. The mean LogMAR visual acuity for both groups on day 1 (Group 1- 0.3 ± 0.1, Group 2- 0.5 ± 0.2) and day 30 (Group 1- 0.1 ± 0.2, Group 2- 0.1 ± 0.1) was statistically significant (P < 0.001), and the mean IOP value showed a statistically significant value (P < 0.009) on day 1 in Group 2 (15.0 ± 2.4 mmHg) and on day 30 (P < 0.001) in both the groups (Group 1- 13.6 ± 1.8 mmHg, Group 2- 13.5 ± 2 mmHg). The horizontal and vertical k values also showed a statistically significant difference on day 1 and day 30 (P < 0.001). The mean percentage change of central corneal thickness (CCT) in Group 1 was 17.7% and in Group 2 was 17.4% on day 1, and it was 1.1% on day 30 in both the groups, which was statistically significant (P < 0.001) compared to preoperative values. The percentage change in endothelial cell density on day 1 was 9% in Group 1 and 4.6% in Group 2, which was statistically significant (P < 0.001). On day 30, it was 9.7% and 4.8%, respectively, which was statistically significant (P < 0.001). Conclusion: Our study highlights statistically significant endothelial cell loss with viscoelastic-assisted nuclear delivery compared to BSS-assisted nuclear delivery during MSICS in a short follow-up of 1 month. The CCT values showed a slight increase, and the keratometry and IOP were unaffected compared to the preoperative parameters in both the groups.

Indexed as

CataractCataract ExtractionPhacoemulsificationSurgical WoundAgedAged, 80 and overCell CountCorneal Endothelial Cell LossFemaleHumansLens Implantation, IntraocularMaleMiddle AgedProspective StudiesSodium ChlorideSodium ChlorideBalanced salt solutionendothelial cell countmanual small-incision cataract surgery (MSICS)nucleus extractionviscoelastic

Identifiers

PMID36308135
PMCPMC9907241
OpenAlexW4307845225

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.